Kade’s Patient Testimonial Transcript

GRAPHIC: SKYRIZI Logo and countdown

SUPER:
USE
SKYRIZI is a prescription medicine used to treat moderate to severe Crohn's disease in adults.

SAFETY CONSIDERATIONS

Do not use if you are allergic to SKYRIZI. SKYRIZI may cause serious side effects, including serious allergic reactions, an increased risk of infections, and liver problems.

  • Stop using SKYRIZI and get emergency medical help right away if experiencing symptoms of a serious allergic reaction.
  • Before starting treatment, your doctor should check for infections and tuberculosis. Tell your doctor right away about any infections or symptoms of infection and about planned or recent vaccines.
  • Liver problems may happen while being treated for Crohn’s disease or ulcerative colitis that can lead to hospitalization. Your doctor will do liver blood tests before and during treatment and may stop SKYRIZI if liver problems develop.

Please see additional Important Safety Information near the end of this video. Please see link for the Full Prescribing Information, including the Medication Guide, for SKYRIZI.

KADE: My name is Kade. I'm 25 years old from Baton Rouge, Louisiana, and I have moderate to severe Crohn's disease.

GRAPHIC: KADE
A SKYRIZI PATIENT

KADE: Finding out that I had Crohn's disease was upsetting, surprising. I was confused.

KADE: The stomach issues and the pain was unbearable. It’s like someone was punching you in the stomach.

KADE: Bathroom visits were very frequent, between 8 to 10 times a day.

KADE: It started eating away at my energy. I was always tired, didn’t want to get out of bed.

KADE: Having support with Crohn's disease is very important, especially your family. My grandparents have been a big part of my life. Being out here on their property, it’s very relaxing.

KADE: When I got diagnosed with Crohn’s disease, my interaction with my specialist was amazing. We tried a few different treatments. I still had pain, I still had the discomfort, still couldn’t eat things. It all changed once I was introduced to SKYRIZI.

GRAPHIC: SKYRIZI Logo

KADE: When I started taking SKYRIZI, I started noticing results four weeks in, in a reduction of pain, and bowel movements.

SUPER: SKYRIZI can help achieve SIGNIFICANT SYMPTOM RELIEF
LESS ABDOMINAL PAIN
FEWER BOWEL MOVEMENTS
AT 4 WEEKS

SUPER: SKYRIZI can help achieve significant symptom relief, including less abdominal pain and fewer bowel movements, as early as 4 weeks.

SUPER: In clinical trials, SKYRIZI helped achieve endoscopic improvement at Week 12 meaning at least a 50 percent visible improvement of the intestinal lining as well as clinical remission at Week 12.

KADE: I do love my food. I can venture out without having an upset stomach. I can actually sit down and eat the plate instead of looking at it.

KADE: My bowel movements have gone back to normal. Instead of 8 to 10 times a day, it's 2 times a day.

KADE: It does make me feel confident that I don’t have to go to the bathroom constantly.

KADE: I can hop in my car without issues.

KADE: Sharing my story will hopefully help others to finding the treatment they need; that takes talking to your doctor, developing a good relationship with them, and finding out if this is the treatment for you.

GRAPHIC: SKYRIZI Logo

SUPER: Please continue watching this video for additional Important Safety Information

VO/SUPER:

USE AND IMPORTANT SAFETY INFORMATION

SKYRIZI® (risankizumab-rzaa) USE

SKYRIZI is a prescription medicine used to treat moderate to severe Crohn’s disease in adults.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about SKYRIZI® (risankizumab-rzaa)?

SKYRIZI is a prescription medicine that may cause serious side effects, including: 

Serious allergic reactions:

  • Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:

    • -fainting, dizziness, feeling lightheaded (low blood pressure)

    -swelling of your face, eyelids, lips, mouth, tongue, or throat

    -trouble breathing or throat tightness

    -chest tightness

    -skin rash, hives

    -itching

Infections:
SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI. 
  • Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:

    • -fever, sweats, or chills

    -cough

    -shortness of breath

    -blood in your mucus (phlegm)

    -muscle aches

    -warm, red, or painful skin or sores on your body different from your psoriasis

    -weight loss

    -diarrhea or stomach pain

    -burning when you urinate or urinating more often than normal

Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.

Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:

  • have any of the conditions or symptoms listed in the section “What is the most important information I should know about SKYRIZI?”
  • have an infection that does not go away or that keeps coming back.
  • have TB or have been in close contact with someone with TB.
  • have recently received or are scheduled to receive an immunization (vaccine). Medicines that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine.
  • are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk.
  • become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of SKYRIZI?

SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”

Liver problems may happen while being treated for Crohn’s disease or ulcerative colitis: A person with Crohn’s disease who received SKYRIZI through a vein in the arm developed changes in liver blood tests with a rash that led to hospitalization. Your healthcare provider will do blood tests to check your liver before, during, and at least up to 12 weeks of treatment, and may stop treatment with SKYRIZI if you develop liver problems. Tell your healthcare provider right away if you notice any of the following symptoms: unexplained rash, nausea, vomiting, stomach (abdominal) pain, tiredness (fatigue), loss of appetite, yellowing of the skin and eyes (jaundice), and dark urine.

The most common side effects of SKYRIZI in people treated for Crohn’s disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach (abdominal) pain, injection site reactions, low red blood cells (anemia), fever, back pain, urinary tract infection, and rash.

These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects.

Use SKYRIZI exactly as your healthcare provider tells you to use it.

SKYRIZI (risankizumab-rzaa) is available in a 600 mg/10 mL vial for intravenous infusion and a 180 mg/1.2 mL or 360 mg/2.4 mL single-dose prefilled cartridge with on-body injector.

Please see the full Prescribing Information, including the Medication Guide, for SKYRIZI.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.

© 2024 AbbVie. All rights reserved.

SKYRIZI® and its design are registered trademarks of AbbVie Biotechnology Ltd.

US-SKZG-240812